The Eyerising Myopia Management Device uses patented repeated low-level red-light (RLRL) technology to emit visible red light from a laser diode. This red light is delivered to the back of the eye, where it can help slow myopia progression by slowing the elongation of the eye.  
‍
RLRL therapy involves 3 minutes of treatment, twice a day, 5 days per week, and with a minimum of 4 hours between sessions. The device is controlled via a simple touchscreen.
‍
It is suitable for children as young as 3 years of age, who can use the device under parental or guardian supervision. The device then monitors and shares patient compliance data with your eye care professional.

The Eyerising Myopia Management Device monitors and encourages patient compliance by automatically sending reminders to the parent or guardian when a treatment is missed, and securely sharing patient compliance data with eye care professionals for their review.